Document is current
Any future updates will be listed below
-
Authors
Tran, Seav-Ly https://orcid.org/0000-0001-7014-6601
Lebreuilly, Lucie https://orcid.org/0009-0002-2774-0538
Cormontagne, Delphine
Samson, Samantha https://orcid.org/0000-0001-9414-140X
Tô, Thu Ba
Stosskopf, Marie
Dervyn, Rozenn
Grießhammer, Anne https://orcid.org/0000-0002-1624-1365
de la Cuesta-Zuluaga, Jacobo https://orcid.org/0000-0002-7369-992X
Maier, Lisa https://orcid.org/0000-0002-6473-4762
Naas, Thierry https://orcid.org/0000-0001-9937-9572
Mura, Simona
Rognan, Didier https://orcid.org/0000-0002-0577-641X
Nicolas, Julien https://orcid.org/0000-0002-1597-0873
André, Gwenaëlle
Ramarao, Nalini https://orcid.org/0000-0001-6045-8521
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 18 March 2025
First Online: 28 April 2025
Competing interests
: S.T., N.R., and D.R. declare the following competing interests: a patent application (EP3868376, 2021) has been published, describing the use of NM102 and its derivatives as antibiotics. The remaining authors declare no competing interests.
